ACADIA Pharmaceuticals Inc. vs Hims and Hers Health Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Hims and Hers Health Inc trades at $30.6 (market cap $7.12B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | HIMS | |
|---|---|---|
Market Cap | $5.07B | $7.12B |
Sector | Health | Health |
52-Week High | $29.41 | $62.76 |
52-Week Low | $20.06 | $14.52 |
Enterprise Value | $4.19B | $7.82B |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →